John Hassard, PhD, Non-exec Director
John co-founded deltaDOT with technology originating in the Department of Physics’ High Energy Physics Group at Imperial. He joined Imperial College as a lecturer in 1986 and remains on the faculty. Before Imperial College, John was a research fellow at Harvard University and Cornell University researching heavy quark decays. He was a special advisor to the House of Commons Select Committee for Science and Technology, and he also founded other spin out companies from Imperial College on physics-based technologies. John was Chief Executive Officer of deltaDOT in its early days and also of deltaDOT’s Qatar based sister company deltaDOT-QSTP LLC.
Carolyn Hyde, PhD, Non-exec Director
Carolyn obtained her degree at University College, Cardiff. She went on to do her PhD at the School of Pharmacy, University of London. This was followed by a post-doctoral fellowship in Peptide Synthesis at the Laboratory of Molecular Biology, Cambridge. Carolyn’s next position was at the MRC (Medical Research Council) Clinical Sciences Centre, helping to run a core facility making and analysing peptides and DNA.
Board – (Executive Directors)
Nigel Stokes, M.Eng MBA, Managing Director
Nigel brings financial and legal expertise to deltaDOT, and has many years’ experience in running and advising SMEs. In addition to his MEng from Imperial College he also holds an MBA from London Business School. Nigel previously worked at deltaDOT from 2001 for several years as Company Secretary and Financial Controller. In 2006, he set up a company based at Saint Mary’s Hospital which performs a novel form of non-invasive surgery to treat fibroids. The equipment was sold to the National Health Service in 2014 and investors received a 2x return. In 2010, he returned to deltaDOT by arranging a funding round which achieved a change in the management and a complete simplification of the company’s governance structures.
Stuart Hassard, PhD, CSO
Stuart co-founded deltaDOT, contributing his molecular biology expertise. He has a Ph.D. in Molecular Biology from the University of Essex, UK. His post-doctoral position was at the United States Department of Agriculture in their Plum Island Animal Disease Center in New York State, working on Foot-and-Mouth disease. He returned to the UK to work at the Department of Medicine at the University of Cambridge on the packaging signal of HIV-1. In 1999, he moved to the department of Biology in Imperial College London and subsequently to the Institute of Biomedical Engineering as a collaborating investigator. Stuart is also IP director for deltaDOT Ltd. and a member for the BBSRC grants assessment committee.
Gary Taylor, PhD, Head of Analysis
Gary is responsible for the implementation and development of algorithms which power deltaDOT’s instrumentation. He came to deltaDOT after his PhD at Imperial College in the field of High Energy Physics (CP violation in B meson decays). Techniques from high energy particle collisions have been adopted for deltaDOT HPCE used in PEREGRINE l.
Lesley Caldwell, PhD, Research Scientist
Lesley came to deltaDOT after completing her undergraduate degree in physics at London university. She rejoined recently following the completion of her MPhil and PhD from the University of Cambridge in the field of Biophysics and Neuroscience.
Marsel Awadalla, Research Scientist
Marsel joined deltaDOT after completing his postgraduate degree in Forensic Science, at King’s College London. He also holds a BSc in Biology with Honours and is applying his multidisciplinary background on projects within the scope of Analytical Chemistry.
Angel Cheng, Admin & Translation
Angel is studying for The Bachelor of Veterinary Medicine course at the Royal Veterinary College. She is assisting us on a part-time basis with administrative tasks, and she also handles translation requirements relating to our collaboration with a Chinese company.